Keryx Biopharmaceuticals Surges 20% Following Positive Phase 3 Data Release

Market News and Data brought to you by Benzinga APIs
Posted In: NewsAnemiaBiopharmaceutical CompaniesChronic Kidney DiseaseJohn Neylankeryx biopharmaceuticalsRenal Diseases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...